Episode 40: Mary Anne Urlakis interviews Dr. Al Kertz on the reliability of information regarding the origin of the COVID19 (May 4, 2020)
4 de may. de 2020 ·
1h 1m 35s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Dr. Al Kertz is Dr. Mary Anne Urlakis’ guest on Episode 40 of “Inter Vitam et Mortem: Between Life & Death: Interviews and Discussion with a Catholic Bioethicist.” Dr. Kertz...
mostra más
Dr. Al Kertz is Dr. Mary Anne Urlakis’ guest on Episode 40 of “Inter Vitam et Mortem: Between Life & Death: Interviews and Discussion with a Catholic Bioethicist.” Dr. Kertz earned his Ph.D. in Animal Nutrition from Cornell University, as well as a B.S. and M.S. from the University of Missouri and is a distinguished member of the American Dairy Science Association. Dr. Kertz is also a member of the Institute for Theological Encounter with Science and Technology. As a renown scientist and authority in the field of Dairy Science, Dr. Kertz is a highly-sought-after consultant, sharing his expertise in the United States and abroad. Dr. Kertz has traveled to China approximately 30 times, and has visited 15 of the 22 provinces, 3 of the 4 major metropolitan areas, and flown into 14 airports. As both a scientist and as an individual who has traveled extensively in China, Dr. Kertz is able to share a unique perspective. In this episode, Dr. Kertz and Dr. Urlakis explore issues regarding the current COVID19 Pandemic and discuss the implicit challenges to bioethical analysis in this rapidly changing situation. Among the topics they discuss are the reliability of information and data regarding the origin of the COVID19 virus and the far-reaching ramifications of scientific discovery in this unique moment in history. (May 4, 2020)
mostra menos
Información
| Autor | WCAT Radio |
| Organización | WCAT Radio |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
